by Vicki Batts, Natural News:
Older individuals living with Alzheimer’s disease are often prescribed antipsychotic drugs. This controversial practice has been frowned upon for many years. New research has now found that the use of these drugs in Alzheimer’s patients substantially increases their risk of mortality — which begs the question: is this risky practice being conducted with malicious intentions?
The majority of people who suffer from Alzheimer’s disease are 65 years of age or older. It affects over five million people in the United States alone, but it is estimated by the year 2050, that number will reach up to 16 million. And in 2016, it was estimated that Alzheimer’s disease and other types of dementia would cost the US roughly $216 billion. It is costly and time-consuming — by 2050, it is expected the costs of caring for people with some form of dementia will reach a devastating $1 trillion.
In other words: to promoters of the depopulation agenda, old people with Alzheimer’s disease are an easy target. They’re costly and they can’t function independently; a more cynical person might even say that they are a drain on the system. And in many nursing homes, patients with dementia or Alzheimer’s disease are often given antipsychotic drugs simply to keep them quiet and placid in their new environment — even in spite of the tremendous risks they pose.
Between the years of 2005 and 2011, a team of researchers studied some 58,000 patients with Alzheimer’s disease. Just over 25 percent of the patients in the study were prescribed some type of antipsychotic medication. Those taking the drugs exhibited a stark increase in mortality risk; they were 60 percent more likely to die because of their medication.
The risk of death was at its peak when patients first began to take the new drugs, but the patients’ mortality risk remained elevated even when the drugs were taken long-term. Patients that were taking more than one antipsychotic exhibited an even higher risk than those taking just one of the risky medications; taking two nearly doubled the chances of dying early. [RELATED: Keep up with the latest research at Scientific.news]
While the study found a correlation between taking an antipsychotic and a higher risk of death in Alzheimer’s patients, a direct cause-and-effect link was not ascertained. The research team, led by Marjaana Koponen, a doctoral student from the School of Pharmacy at the University of Eastern Finland, does say that their findings support previous data, however.
Please follow SGT Report on Twitter & help share the message.